RESISTANT CANCER

Clinical trials for RESISTANT CANCER explained in plain language.

Never miss a new study

Get alerted when new RESISTANT CANCER trials appear

Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New combo aims to control resistant liver cancer

Disease control Terminated

This study tested whether adding an experimental drug (VIC-1911) to the standard drug lenvatinib could help people with liver cancer that no longer responds to lenvatinib alone. Only 5 people were enrolled before the study was stopped early. The goal was to see if the combination…

Matched conditions: RESISTANT CANCER

Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:26 UTC

RESISTANT CANCER

Get alerted when new RESISTANT CANCER trials appear

New combo aims to control resistant liver cancer